Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04205552 |
| Title | Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict) |
| Acronym | NEOpredict |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Hospital, Essen |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD | DEU | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Jessa Hospital Hasselt | RECRUITING | Hasselt | Belgium | Details | ||
| University Hospital Essen | RECRUITING | Essen | Germany | Details | ||
| Thoraxklinik Heidelberg gGmbH-Universitätsklinikum Heidelberg | RECRUITING | Heidelberg | 69126 | Germany | Details | |
| Netherlands Cancer Institute | RECRUITING | Amsterdam | Netherlands | Details |